ℹ️
🇬🇧
Search
Search for publications relevant for "Globotriaosylceramide"
Globotriaosylceramide
Publication
Class
Person
Publication
Programmes
publication
Tandem mass spectrometry of globotriaosylceramide: quantification in plasma and urine for diagnosis and therapy monitoring in Fabry disease
+1
2007 |
First Faculty of Medicine
publication
Setting up of globotriasylceramid in serum and urine in Fabry disease
Publication without faculty affiliation
publication
Tandem mass spectrometry of globotriaosylceramide in plasma and urine for diagnosis and therapy monitoring in Fabry disease
Publication without faculty affiliation
publication
Tandem mass spectrometry of globotriaosylceramide in human plasma and urine for diagnosis and therapy monitoring in Fabry disease
Publication without faculty affiliation
publication
Tandem mass spectrometry of globotriaosylceramide in plasma and urine: strategy for diagnosis and therapy monitoring in Fabry disease
Publication without faculty affiliation
publication
Tandem mass spectrometry of globotriaosylceramide in plasma and urine : method of choice for diagnosis and ERT monitoring classic type of Fabry disease
Publication without faculty affiliation
publication
Preparation of recombinant subunit B of Verotoxine E. Coli specifice for globotriaosylceramid receptor
Publication without faculty affiliation
publication
Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease
2009 |
First Faculty of Medicine
publication
Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies
2023 |
First Faculty of Medicine
publication
Biochemistry of Fabry Disease
2010 |
First Faculty of Medicine
publication
Nationwide screening for Fabry disease in unselected stroke patients
2021 |
First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Anderson-Fabry disease
2013 |
First Faculty of Medicine
publication
Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial
2019 |
First Faculty of Medicine
publication
Morbus Fabry - skin and soft-tissue manifestations
2019 |
First Faculty of Medicine
publication
Serum Bilirubin Levels and Promoter Variations in HMOX1 and UGT1A1 Genes in Patients with Fabry Disease
2017 |
First Faculty of Medicine
publication
Fabry's disease from the point of view of nephrology
2015 |
First Faculty of Medicine
publication
Tandem Mass Spectrometry of Sphingolipids: Applications for Diagnosis of Sphingolipidoses
2016 |
First Faculty of Medicine
publication
Tandem mass spectrometry of sphingolipids: Application in metabolic studies and diagnosis of inherited disorders of sphingolipid metabolism
2012 |
First Faculty of Medicine
publication
Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease
2015 |
First Faculty of Medicine
publication
Střádavá onemocnění v nefrologii
2016 |
First Faculty of Medicine
publication
Glycosphingolipid profile of the apical pole of human placental capillaries: The relevancy of the observed data to Fabry disease
2012 |
First Faculty of Medicine
publication
An expert consensus document on the management of cardiovascular manifestations of Fabry disease
2020 |
First Faculty of Medicine
publication
Specific storage of glycoconjugates with terminal alpha-galactosyl moieties in the exocrine pancreas of Fabry disease patients with blood group B
2018 |
First Faculty of Medicine
publication
Characterization of Early Disease Status in Treatment-Naive Male Paediatric Patients with Fabry Disease Enrolled in a Randomized Clinical Trial
2015 |
First Faculty of Medicine
publication
Fabry disease: renal sphingolipid distribution in the alpha-Gal A knockout mouse model by mass spectrometric and immunohistochemical imaging
2015 |
First Faculty of Medicine
publication
Narrative review on Morbus Fabry: diagnosis and management of cardiac manifestations
2021 |
First Faculty of Medicine
publication
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
2019 |
First Faculty of Medicine
publication
Defects in degradation of blood group A and B glycosphingolipids in Schindler and Fabry diseases
2002 |
First Faculty of Medicine